Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
54.7M
-
Shares change
-
-1.94M
-
Total reported value, excl. options
-
$131M
-
Value change
-
-$11.1M
-
Put/Call ratio
-
1.1
-
Number of buys
-
55
-
Number of sells
-
-44
-
Price
-
$2.39
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2018
123 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2018.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.7M shares
of 123M outstanding shares and own 44.41% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (6.81M shares), Consonance Capital Management LP (4.99M shares), BlackRock Inc. (4.7M shares), venBio Select Advisor LLC (4.69M shares), BAKER BROS. ADVISORS LP (4.38M shares), VANGUARD GROUP INC (3.98M shares), GREAT POINT PARTNERS LLC (2.7M shares), MANGROVE PARTNERS (1.51M shares), RENAISSANCE TECHNOLOGIES LLC (1.39M shares), and MILLENNIUM MANAGEMENT LLC (1.38M shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.